598 related articles for article (PubMed ID: 16139690)
1. Endogenous cardiac glycosides: hormones using the sodium pump as signal transducer.
Schoner W; Scheiner-Bobis G
Semin Nephrol; 2005 Sep; 25(5):343-51. PubMed ID: 16139690
[TBL] [Abstract][Full Text] [Related]
2. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
Schoner W; Scheiner-Bobis G
Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
[TBL] [Abstract][Full Text] [Related]
3. Endogenous cardiotonic steroids.
Schoner W
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
[TBL] [Abstract][Full Text] [Related]
4. Endogenous cardiac glycosides, a new class of steroid hormones.
Schoner W
Eur J Biochem; 2002 May; 269(10):2440-8. PubMed ID: 12027881
[TBL] [Abstract][Full Text] [Related]
5. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
6. [New steroid hormone family: endogenous cardiac glycosides and their role in physiologic and pathologic conditions].
Somogyi J; Szalay J; Pándics T; Rosta K; Csermely P; Vér A
Orv Hetil; 2004 Feb; 145(6):259-66. PubMed ID: 15038319
[TBL] [Abstract][Full Text] [Related]
7. Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.
Hauck C; Frishman WH
Cardiol Rev; 2012; 20(3):130-8. PubMed ID: 22183064
[TBL] [Abstract][Full Text] [Related]
8. Short-term effects of cardiac steroids on intracellular membrane traffic in neuronal NT2 cells.
Rosen H; Glukmann V; Feldmann T; Fridman E; Lichtstein D
Cell Mol Biol (Noisy-le-grand); 2006 Dec; 52(8):78-86. PubMed ID: 17535740
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation.
Touza NA; Pôças ES; Quintas LE; Cunha-Filho G; Santos ML; Noël F
Life Sci; 2011 Jan; 88(1-2):39-42. PubMed ID: 21047518
[TBL] [Abstract][Full Text] [Related]
10. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway.
Arnaud-Batista FJ; Costa GT; Oliveira IM; Costa PP; Santos CF; Fonteles MC; Uchôa DE; Silveira ER; Cardi BA; Carvalho KM; Amaral LS; Pôças ES; Quintas LE; Noël F; Nascimento NR
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F959-66. PubMed ID: 22237798
[TBL] [Abstract][Full Text] [Related]
12. Low-dose cardiotonic steroids increase sodium-potassium ATPase activity that protects hippocampal slice cultures from experimental ischemia.
Oselkin M; Tian D; Bergold PJ
Neurosci Lett; 2010 Apr; 473(2):67-71. PubMed ID: 19822191
[TBL] [Abstract][Full Text] [Related]
13. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
14. Intrahippocampal microinjection of an exquisitely low dose of ouabain mimics NaCl loading and stimulates a bufadienolide Na/K-ATPase inhibitor.
Fedorova OV; Zhuravin IA; Agalakova NI; Yamova LA; Talan MI; Lakatta EG; Bagrov AY
J Hypertens; 2007 Sep; 25(9):1834-44. PubMed ID: 17762648
[TBL] [Abstract][Full Text] [Related]
15. Effects of cardiac glycosides on sodium pump expression and function in LLC-PK1 and MDCK cells.
Liu J; Periyasamy SM; Gunning W; Fedorova OV; Bagrov AY; Malhotra D; Xie Z; Shapiro JI
Kidney Int; 2002 Dec; 62(6):2118-25. PubMed ID: 12427136
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous cardiotonic steroids in sodium homeostasis.
Schoner W; Scheiner-Bobis G
Nephrol Dial Transplant; 2008 Sep; 23(9):2723-9. PubMed ID: 18556748
[No Abstract] [Full Text] [Related]
17. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
Gentile DA; Henry J; Katz AJ; Skoner DP
Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
[TBL] [Abstract][Full Text] [Related]
19. Ouabain interaction with cardiac Na/K-ATPase reveals that the enzyme can act as a pump and as a signal transducer.
Xie Z
Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):383-90. PubMed ID: 11357899
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte sodium pump stimulation by ouabain and an endogenous ouabain-like factor.
Balzan S; D'Urso G; Nicolini G; Forini F; Pellegrino M; Montali U
Cell Biochem Funct; 2007; 25(3):297-303. PubMed ID: 17191274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
